64,604 Shares in Baxter International Inc. $BAX Purchased by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. acquired a new position in shares of Baxter International Inc. (NYSE:BAX – Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 64,604 shares of the medical instruments supplier’s stock, valued at approximately $1,550,000.

Several other large investors have also recently modified their holdings of BAX. BlackRock Inc. purchased a new position in Baxter International in the second quarter worth $1,744,874,000. Pzena Investment Management LLC acquired a new position in shares of Baxter International during the second quarter worth $1,392,098,000. Equity Investment Corp purchased a new stake in shares of Baxter International during the 2nd quarter valued at $146,815,000. Bank of America Corp DE purchased a new stake in shares of Baxter International during the 2nd quarter valued at $132,993,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Baxter International during the 2nd quarter valued at $68,036,000. Institutional investors own 90.19% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on BAX. TD Cowen boosted their target price on Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research note on Monday, July 27th. Wall Street Zen upgraded Baxter International from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. Wells Fargo & Company increased their price target on Baxter International from $23.00 to $25.00 and gave the company an “equal weight” rating in a research note on Friday, October 30th. Zacks Research raised Baxter International from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. Finally, Citigroup dropped their price target on Baxter International from $28.00 to $27.00 and set a “neutral” rating on the stock in a research note on Monday, October 5th. One research analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $23.27.

Get Our Latest Stock Report on Baxter International

Baxter International Stock Down 0.2%

Shares of BAX stock opened at $25.77 on Monday. Baxter International Inc. has a twelve month low of $15.73 and a twelve month high of $30.00. The stock has a market cap of $13.33 billion, a P/E ratio of -18.28, a P/E/G ratio of 3.79 and a beta of 0.68. The stock has a 50 day moving average of $24.54 and a 200 day moving average of $21.67. The company has a current ratio of 1.79, a quick ratio of 1.19 and a debt-to-equity ratio of 1.20.

Baxter International (NYSE:BAX – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 EPS for the quarter, topping the consensus estimate of $0.52 by $0.06. The business had revenue of $2.98 billion for the quarter, compared to analyst estimates of $2.91 billion. Baxter International had a positive return on equity of 16.23% and a negative net margin of 6.23%. The business’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.69 EPS. As a group, sell-side analysts expect that Baxter International Inc. will post 2.10 EPS for the current year.

Baxter International Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, November 27th will be paid a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, November 27th. Baxter International’s payout ratio is currently -2.84%.

About Baxter International

(Free Report)

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.

Recommended Stories

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.